Skip to main content

Table 2 General characteristics of HIV-infected study subjects

From: Greater frequency of CD5-negative CD8+ T cells against human immunodeficiency virus type 1 than other viruses is consistent with adaptation to antigenic variation

ID Age (years) Sex Duration of HIV infection (years) CD4+T cells/μL peripheral blood Virus loada Treatmentb
11 44 Female >20 200 2.81 cART
12 40 Male >20 518 <1.6 cART
18 37 Male >20 729 1.97 cART
28 45 Male >20 144 4.94 None
30 50 Male >20 884 <1.6 cART
34 37 Female >20 450 3.26 cART
35 52 Male >25 882 1.6 cART
39 38 Female >20 506 2.74 cART
43 49 Male >20 450 4.15 None
45 42 Female >20 456 <1.6 cART
62 38 Female >20 720 <1.6 cART
65 54 Female >20 306 <1.6 cART
71 38 Female >20 860 <1.6 cART
78 41 Male >20 150 2.73 cART
90 42 Female >10 315 <1.6 cART
92 36 Female >15 325 5.5 None
96 44 Female >15 812 <1.6 cART
105 46 Male >10 527 2.15 cART
115 44 Female >10 704 <1.6 cART
117 45 Male >15 322 <1.6 cART
125 51 Male >10 420 <1.6 cART
126 50 Male >10 754 <1.6 cART
132 37 Female >15 30 5.53 None
134 44 Female >20 780 <1.6 cART
151 54 Male >10 360 <1.6 cART
154 47 Male >20 442 <1.6 cART
155 41 Female >5 500 <1.6 cART
179 44 Male >5 984 <1.6 cART
181 39 Male >20 104 4.79 None
193 43 Female >5 420 <1.6 cART
196 54 Male >5 273 <1.6 cART
197 59 Male >5 616 <1.6 cART
201 52 Male >5 434 <1.6 cART
204 42 Female >20 437 <1.6 cART
213 55 Female >5 561 <1.6 cART
  1. aVirus load is expressed in log10 copies HIV RNA/ml plasma.
  2. bCombination antiretroviral therapy (cART) represents various two or three class highly active antiretroviral drug regimens.